Jeffrey S. Farrow, See Remarks at Tarsus Pharmaceuticals, Inc. (TARS), sold 7,448 shares at $46.29 ($357K) on 2025-03-18, disclosed to the SEC on 2025-03-20.
Open-market sale of $357k TARS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.29 | 1,284 | $59K | 16.7% |
| 2 | $46.29 | 1,284 | $59K | 16.7% |
| 3 | $47.40 | 1,254 | $59K | 16.7% |
| 4 | $47.40 | 1,254 | $59K | 16.7% |
| 5 | $50.11 | 1,186 | $59K | 16.7% |
| 6 | $50.11 | 1,186 |
| $59K |
| 16.7% |
| Total | $47.88 avg | 7,448 | $357K | 100% |
| Filing → |
| TARS | SELL | 2025-06-18 | $1.1M | — | Filing → |
| TARS | SELL | 2024-06-20 | $574K | — | Filing → |
| GBT | SELL | 2022-09-06 | $2.1M | — | Filing → |